Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors
View/ Open
Author
Rimm, Eric Bruce::0ab2926c8242f35e5a982e3cf59f4987::600
Williams, Paige
Fosher, Kerry
Criqui, Michael
Published Version
https://doi.org/10.1136/bmj.319.7224.1523Metadata
Show full item recordCitation
Rimm, E. B, P. Williams, K. Fosher, M. Criqui, and M. J Stampfer. 1999. “Moderate Alcohol Intake and Lower Risk of Coronary Heart Disease: Meta-Analysis of Effects on Lipids and Haemostatic Factors.” BMJ 319 (7224): 1523–28. https://doi.org/10.1136/bmj.319.7224.1523.Abstract
Objective To summarise quantitatively the association between moderate alcohol intake and biological markers of risk of coronary heart disease and to predict how these changes would lower the risk.Design Meta-analysis of all experimental studies that assessed the effects of moderate alcohol intake on concentrations of high density lipoprotein cholesterol, apolipoprotein A I, fibrinogen, triglycerides, and other biological markers previously found to be associated with risk of coronary heart disease.Participants Men and woman free of previous chronic disease and who were not dependent on alcohol. Studies were included in which biomarkers were assessed before and after participants consumed up to 100 g of alcohol a dal:Interventions Alcohol as ethanol, beer, wine, or spirits.Main outcome measures Changes in concentrations of high density lipoprotein cholesterol, apolipoprotein A I, Lp(a) lipoprotein, triglycerides, tissue type plasminogen activator activity, tissue type plasminogen activator antigen, insulin, and glucose after consuming an experimental dose of alcohol for 1 to 9 weeks; a shelter period was accepted for studies of change in concentrations of fibrinogen, factor VIT, von Willebrand factor, tissue type plasminogen activator activity and tissue type plasminogen activator antigen.Results 61 data records were abstracted from 42 eligible studies with information on change in biological markers of risk of coronary heart disease. An experimental dose of 30 g of ethanol a day increased concentrations of high density lipoprotein cholesterol by 3.99 mg/dl (95% confidence interval 3.25 to 4.73), apolipoprotein A I by 8.82 mg/dl (7.79 to 9.86), and triglyceride by 5.69 mg/dl (2.49 to 8.89). Several haemostatic factors related to a thrombolytic profile were modestly affected by alcohol. On the basis of published associations between these biomarkers and risk of coronary heart disease 30 g of alcohol a day would cause an estimated reduction of 24.7% in risk of coronary heart disease.Conclusions Alcohol intake is causally related to lower risk of coronary heart disease through changes in lipids and. haemostatic factors.Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:41254591
Collections
- SPH Scholarly Articles [6353]
Contact administrator regarding this item (to report mistakes or request changes)